ADRA2A polyclonal, anti-human, mouse, rat, bovine, rabbit, pig
€320.00
In stock
SKU
251433
Catalog Nr.: 251433
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Protein Family: Receptors and Channels
Pathway and Disease: Signaling Molecules and Interaction
Description:
Alpha-2 adrenergic receptors (ADRA2) mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. ADRA2 is involved in a number of physiological responses to agonist activation, including the inhibition of insulin release and stimulation of glucagon release from the pancreas, decreased motility of smooth muscle in the gastrointestinal tract, vasodilation of arteries, and vasoconstriction of veins.
Alternate Names: Alpha-2A adrenergic receptor, Alpha-2 adrenergic receptor subtype C10, Alpha-2A, Alpha-2A adrenoceptor, Alpha-2AAR, ADRA2R, ADRAR, ADRA2A
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500
Accession No.: P08913
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human ADRA2.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
Pathway and Disease: Signaling Molecules and Interaction
Description:
Alpha-2 adrenergic receptors (ADRA2) mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. ADRA2 is involved in a number of physiological responses to agonist activation, including the inhibition of insulin release and stimulation of glucagon release from the pancreas, decreased motility of smooth muscle in the gastrointestinal tract, vasodilation of arteries, and vasoconstriction of veins.
Alternate Names: Alpha-2A adrenergic receptor, Alpha-2 adrenergic receptor subtype C10, Alpha-2A, Alpha-2A adrenoceptor, Alpha-2AAR, ADRA2R, ADRAR, ADRA2A
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500
Accession No.: P08913
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human ADRA2.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
| Is Featured? | No |
|---|
Write Your Own Review